移植NAFLD患者和健康人粪菌对高脂饮食大鼠肠道菌群的影响*

doi:10.3969/j.issn.1672-5069.2020.01.036

实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (1): 134-137.doi: 10.3969/j.issn.1672-5069.2020.01.036

移植NAFLD患者和健康人粪菌对高脂饮食大鼠肠道菌群的影响^*

骆庆玲, 周永健, 唐文娟, 首第文, 黄红丽, 徐豪明, 黄惠康, 何杰, 杜艳蕾, 阮焕梅, 陈慧婷, 曹创裕

510030 广州市广州医科大学附属广州市第一人民医院消化科

收稿日期:2019-01-20 出版日期:2020-01-10 发布日期:2020-01-14
通讯作者: 周永健,E-mail:yjzhou@gzhmu.edu.cn
作者简介:骆庆玲,女,26岁,硕士研究生,住院医师。主要从事消化系统疾病与肠道菌群研究。E-mail:18826401762@163.com
基金资助:
广州市医药卫生科技项目(编号：20181A011007);广州市卫生健康科技项目(项目编号：20191A011001);广州市卫生和计划生育科技项目(20181A011006);广东省医学科学技术研究基金项目(项目编号：20171025211834334)

Effects of fecal bacteria transplantation on microflora in rats with high-fat-induced liver steatosis

Luo Qingling, Zhou Yongjian, Tang Wenjuan, et al

Department of Gastroenterology,First People’s Hospital,Guangzhou Medical University,Guangzhou 510030,Guangdong Province,China

Received:2019-01-20 Online:2020-01-10 Published:2020-01-14

摘要/Abstract

摘要： 目的探讨粪菌移植干预对非酒精性脂肪性肝病(NAFLD)动物肠道菌群的影响。方法将32 只大鼠随机分为ABCD四组,其中3组用混合抗生素抑菌1周后,予以高脂饮食建立NAFLD模型,再分别给予NAFLD患者粪菌或和正常人粪菌移植,检测肠粘膜组织16sDNA菌群。结果模型组Rodentibacter菌群丰度较对照组升高,在NAFLD粪菌移植组升高更显著,而在正常人粪菌移植组则有所下降。结论 NAFLD粪菌群可能是肝脏脂肪变性的一个危险因素,而应用健康人粪菌移植可以改善高脂饮食大鼠脂肪肝病变。

关键词: 非酒精性脂肪性肝病, 肠道菌群, 粪菌移植, 菌群丰度, 大鼠

Abstract: Objective The aim of this study was to investigate the effects of fecal bacteria transplantation (FBT) on microflora in rats with high-fat-induced liver steatosis. Methods 32 rats were randomly divided into group A, B, C and D. The non-alcoholic fatty liver disease (NAFLD) model was established by high-fat feeding, and fecal bacteria transplantation from patients with NAFLD and healthy persons were performed. The 16 sDNA flora of intestinal mucosal tissue were analyzed. Results The content of Rodentibacter in the model group was increased as compared to that in the control, but it increased more greatly in the rats with FBT from NAFLD, and it decreased greatly in rats with FBT from healthy persons. Conclusion The bacteria flora of patients with NAFLD might be a risk factor for hepatic steatosis, and FBT by using healthy person’s feces might alleviate the liver steatosis.

Key words: Nonalcoholic fatty liver disease, Intestinal flora, Fecal bacteria transplantation, Abundance of flora, Rats

骆庆玲, 周永健, 唐文娟, 首第文, 黄红丽, 徐豪明, 黄惠康, 何杰, 杜艳蕾, 阮焕梅, 陈慧婷, 曹创裕. 移植NAFLD患者和健康人粪菌对高脂饮食大鼠肠道菌群的影响^*[J]. 实用肝脏病杂志, 2020, 23(1): 134-137.

Luo Qingling, Zhou Yongjian, Tang Wenjuan, et al. Effects of fecal bacteria transplantation on microflora in rats with high-fat-induced liver steatosis[J]. Journal of Practical Hepatology, 2020, 23(1): 134-137.

参考文献

[1] Younossi Z M, Koenig A B, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology,2016,64(1):73-84.
[2] 池肇春. 非酒精性脂肪性肝炎肝硬化发病机制研究进展与展望. 实用肝脏病杂志,2018,21(2):166-169.
[3] Ridaura V K, Faith J J, Rey F E, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science,2013,341(6150):1241214.
[4] De Palma G, Lynch M D J, Lu J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Translat Med,2017,9(379):f6397.
[5] Li B, Guo K, Zeng L, et al. Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers. Transl Psychiat,2018,8(1):34.
[6] Wong S H, Zhao L, Zhang X, et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology,2017,153(6):1621-1633.
[7] Rabot S, Membrez M, Bruneau A, et al. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J,2010,24(12):4948-4959.
[8] Zeng H, Liu J, Jackson M I, et al. Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-Fat diet. J Nutrit,2013,143(5):627-631.
[9] Zhou D, Pan Q, Xin F Z, et al. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol,2017,23(1):60-75.
[10] Schramm C. Bile acids, the microbiome, immunity, and liver tumors. New Engl J Med,2018,379(9):888-890.
[11] Cheng S L, Li X, Lehmler H J, et al. Gut microbiota modulates interactions between polychlorinated biphenyls and bile acid homeostasis. Toxicol Sci,2018,166(2):269-287.
[12] Zhou D, Pan Q, Shen F, et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep,2017,7(1):1529.
[13] Motonaga K, Ota M, Odawara K, et al. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats. Regul Toxicol Pharmacol,2016,80:283-290.
[14] Akmal A, Kung J. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity. Expert Opin Drug Saf,2014,13(10):1397-1406.
[15] Wang M T, Lee W J, Huang T Y, et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol,2014,78(3):619-629.
[16] Dong L N, Wang J P, Liu P, et al. Faecal and mucosal microbiota in patients with functional gastrointestinal disorders: Correlation with toll-like receptor 2/toll-like receptor 4 expression. World J Gastroenterol,2017,23(36):6665-6673.
[17] Fornefett J, Krause J, Klose K, et al. Comparative analysis of humoral immune responses and pathologies of BALB/c and C57BL/6 wildtype mice experimentally infected with a highly virulent Rodentibacter pneumotropicus (Pasteurella pneumotropica) strain. BMC Microbiol,2018,18(1):45.
[18] Pan H, Guo R, Zhu J, et al. A gene catalogue of the Sprague-Dawley rat gut metagenome. Gigascience,2018,7(5):332-336.
[19] 骆庆玲,周永健. 粪菌移植治疗非酒精性脂肪性肝病研究与思考. 实用肝脏病杂志,2017,20(6):647-650.

移植NAFLD患者和健康人粪菌对高脂饮食大鼠肠道菌群的影响^*

Effects of fecal bacteria transplantation on microflora in rats with high-fat-induced liver steatosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈丽丽, 符茂雄, 蒙绪标, 方其超. 空腹C肽评估NAFLD合并T2DM患者肝纤维化进展价值分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 38-41.
[2]	柳健, 朱峰发, 唐娟. 非均匀性脂肪肝患者腹部超声表现和血脂变化特点^*[J]. 实用肝脏病杂志, 2020, 23(1): 42-45.
[3]	魏重操, 刘娜, 邢欣, 澹台新兴, 杨倩, 蒋潇洒, 王进海. 多烯磷脂酰胆碱联合二甲双胍治疗非酒精性脂肪性肝病患者疗效和安全性Meta分析[J]. 实用肝脏病杂志, 2020, 23(1): 46-49.
[4]	毛重山, 殷辉, 肖二辉, 张英英. 非诺贝特对非酒精性脂肪性肝病合并2型糖尿病患者血脂、血管内皮功能和肝纤维化指标的影响^*[J]. 实用肝脏病杂志, 2020, 23(1): 50-53.
[5]	郭化磊, 卜理琳, 裴颖, 殷宏振, 黄峰. 化浊通瘀汤干预非酒精性脂肪性肝病大鼠血清肿瘤坏死因子-α和瘦素的变化^*[J]. 实用肝脏病杂志, 2020, 23(1): 138-141.
[6]	任俞霏, 陈小青, 孔维宗, 王迎春. 丹酚酸B对非酒精性脂肪性肝病细胞模型自噬功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 804-807.
[7]	徐飞, 李伟荣. 黄芪甲苷对CCL₄所致肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 808-811.
[8]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[9]	李颖怡, 郭翠芬, 章瑞南, 汪保灿, 潘勤, 汪余勤, 曹海霞, 范建高. ALDH2 rs671基因多态性与非酒精性脂肪性肝病相关性研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 848-851.
[10]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[11]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[12]	林秋香, 王雪雯, 黄祖雄, 潘晨. 灯盏花素对肝脏缺血再灌注损伤大鼠肝脏和肠黏膜屏障功能的保护作用*[J]. 实用肝脏病杂志, 2019, 22(5): 636-639.
[13]	石小龙, 杜睿, 秦革萍, 薛华燕, 张宏鑫. 七氟醚对脓毒症大鼠肝损伤的保护作用及其作用机制研究*[J]. 实用肝脏病杂志, 2019, 22(5): 640-643.
[14]	张胥磊, 杨庆余, 韩秋玉, 缪鋆鋆, 蔡仁诚, 马亦旻. 自拟中药治疗非酒精性脂肪性肝病患者血清炎症反应指标水平的变化*[J]. 实用肝脏病杂志, 2019, 22(5): 660-663.
[15]	王艳, 苏峰, 李园园, 李舒. 蜂毒溶血肽改善非酒精性脂肪肝大鼠肝组织脂肪沉积作用及其机制研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 474-477.